NCT05084482

Brief Summary

Delirium is frequently observed among critically ill patients and is associated with detrimental outcomes. Currently, no evidence-based prevention or treatment exists for delirium, and especially, the inability to identify effective preventive measures of delirium has increased the focus on identifying patients with a high risk of delirium through prediction models. Two prediction models have been developed to estimate the risk of delirium in ICU patients: the prediction model for delirium (PRE-DELIRIC) and the early prediction model for delirium (E-PRE-DELIRIC). These robust and well-calibrated prediction models have the potential of assisting in identifying patients with the highest risk for delirium and thereby to focusing preventive strategies on the most vulnerable group. However further validation is needed in a Danish population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
660

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 19, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

April 8, 2025

Status Verified

January 1, 2023

Enrollment Period

1.6 years

First QC Date

October 6, 2021

Last Update Submit

April 4, 2025

Conditions

Keywords

Critical illnessICUDeliriumpredictionObservational

Outcome Measures

Primary Outcomes (2)

  • AUROC for PRE-DELIRIC

    Area Under the Receiver Operating Characteristics (AUROC) for PRE-DELIRIC

    Duration of the study, november 2021 to september 2022

  • AUROC for E-PRE-DELIRIC

    Area Under the Receiver Operating Characteristics (AUROC) for E-PRE-DELIRIC

    Based on 14 days of ICU admission

Secondary Outcomes (4)

  • 30-days mortality

    30 days efter ICU admission

  • Time on ventilator

    14 days after ICU admission

  • ICU length of stay

    30 days after ICU admission

  • Hospital length of stay

    30 days after ICU admission

Study Arms (1)

Adult patients admitted to Intensive Care Unit (ICU)

Eligible patients are scored by E-PRE-DELIRIC at admission and PRE-DELIRIC 24 hours after admission.

Other: Prediction models

Interventions

The prediction scores are validated by the CAM-ICU scores up to 14 days after ICU admission.

Also known as: Delirium, PRE-DELIRIC, E-PRE-DELIRIC
Adult patients admitted to Intensive Care Unit (ICU)

Eligibility Criteria

Age18 Years - 110 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsMale or female
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients admitted to participating ICUs in the Zealand Region between November 2021 and July 2022.

You may qualify if:

  • Acute admission to an ICU AND
  • Age \> 18 of years

You may not qualify if:

  • Total admittance to the ICU less than 24 hours
  • Delirium assessment nonapplicable (hearing or visual disabilities, language barriers, or mentally incompetent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zealand University Hospital, Department of Anaesthesiology

Køge, Zealand Region of Denmark, 4600, Denmark

Location

MeSH Terms

Conditions

DeliriumCritical Illness

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersDisease AttributesPathologic Processes

Study Officials

  • Neeliya Anton Joseph, BSc Medicine

    Department of Anaesthesiology, Zealand University Hospital, Køge, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of ICU

Study Record Dates

First Submitted

October 6, 2021

First Posted

October 19, 2021

Study Start

January 1, 2022

Primary Completion

July 31, 2023

Study Completion

September 30, 2023

Last Updated

April 8, 2025

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share

Individual anonymised participant data will be made available to researchers upon reasonable request after termination and publication of the study.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
After the termination and publication of the study
Access Criteria
Reasonable request by researcher based on study protocol.

Locations